Cargando…
Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases
Prior work has shown that functional connectivity between the midbrain and putamen is altered in patients with impairments in the dopamine system. This study examines whether individual differences in midbrain–striatal connectivity are proportional to the integrity of the dopamine system in patients...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484547/ https://www.ncbi.nlm.nih.gov/pubmed/26137443 http://dx.doi.org/10.1016/j.nicl.2015.06.001 |
_version_ | 1782378683242119168 |
---|---|
author | Rieckmann, A. Gomperts, S.N. Johnson, K.A. Growdon, J.H. Van Dijk, K.R.A. |
author_facet | Rieckmann, A. Gomperts, S.N. Johnson, K.A. Growdon, J.H. Van Dijk, K.R.A. |
author_sort | Rieckmann, A. |
collection | PubMed |
description | Prior work has shown that functional connectivity between the midbrain and putamen is altered in patients with impairments in the dopamine system. This study examines whether individual differences in midbrain–striatal connectivity are proportional to the integrity of the dopamine system in patients with nigrostriatal dopamine loss (Parkinson's disease and dementia with Lewy bodies). We assessed functional connectivity of the putamen during resting state fMRI and dopamine transporter (DAT) availability in the striatum using 11C-Altropane PET in twenty patients. In line with the hypothesis that functional connectivity between the midbrain and the putamen reflects the integrity of the dopaminergic neurotransmitter system, putamen–midbrain functional connectivity was significantly correlated with striatal DAT availability even after stringent control for effects of head motion. DAT availability did not relate to functional connectivity between the caudate and thalamus/prefrontal areas. As such, resting state functional connectivity in the midbrain–striatal pathway may provide a useful indicator of underlying pathology in patients with nigrostriatal dopamine loss. |
format | Online Article Text |
id | pubmed-4484547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-44845472015-07-01 Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases Rieckmann, A. Gomperts, S.N. Johnson, K.A. Growdon, J.H. Van Dijk, K.R.A. Neuroimage Clin Regular Article Prior work has shown that functional connectivity between the midbrain and putamen is altered in patients with impairments in the dopamine system. This study examines whether individual differences in midbrain–striatal connectivity are proportional to the integrity of the dopamine system in patients with nigrostriatal dopamine loss (Parkinson's disease and dementia with Lewy bodies). We assessed functional connectivity of the putamen during resting state fMRI and dopamine transporter (DAT) availability in the striatum using 11C-Altropane PET in twenty patients. In line with the hypothesis that functional connectivity between the midbrain and the putamen reflects the integrity of the dopaminergic neurotransmitter system, putamen–midbrain functional connectivity was significantly correlated with striatal DAT availability even after stringent control for effects of head motion. DAT availability did not relate to functional connectivity between the caudate and thalamus/prefrontal areas. As such, resting state functional connectivity in the midbrain–striatal pathway may provide a useful indicator of underlying pathology in patients with nigrostriatal dopamine loss. Elsevier 2015-06-09 /pmc/articles/PMC4484547/ /pubmed/26137443 http://dx.doi.org/10.1016/j.nicl.2015.06.001 Text en © 2015 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular Article Rieckmann, A. Gomperts, S.N. Johnson, K.A. Growdon, J.H. Van Dijk, K.R.A. Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases |
title | Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases |
title_full | Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases |
title_fullStr | Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases |
title_full_unstemmed | Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases |
title_short | Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases |
title_sort | putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with lewy body diseases |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484547/ https://www.ncbi.nlm.nih.gov/pubmed/26137443 http://dx.doi.org/10.1016/j.nicl.2015.06.001 |
work_keys_str_mv | AT rieckmanna putamenmidbrainfunctionalconnectivityisrelatedtostriataldopaminetransporteravailabilityinpatientswithlewybodydiseases AT gompertssn putamenmidbrainfunctionalconnectivityisrelatedtostriataldopaminetransporteravailabilityinpatientswithlewybodydiseases AT johnsonka putamenmidbrainfunctionalconnectivityisrelatedtostriataldopaminetransporteravailabilityinpatientswithlewybodydiseases AT growdonjh putamenmidbrainfunctionalconnectivityisrelatedtostriataldopaminetransporteravailabilityinpatientswithlewybodydiseases AT vandijkkra putamenmidbrainfunctionalconnectivityisrelatedtostriataldopaminetransporteravailabilityinpatientswithlewybodydiseases |